iX Biopharma Ltd. the announced with effect from 12 November 2018: (1) Mr. Low Weng Keong be re-designated as the Lead Independent Director; and (2) Ms. Claudia Teo Kwee Yee be appointed as the Chairman of the Remuneration Committee. Mr. Low Weng Keong was appointed to the Board as an Independent Director on 18 June 2015 and serves as the Chairman of the Audit Committee and a member of the Nominating, Remuneration and Risk Management Committees. Consequent to the abovementioned changes, with effect from 12 November 2018, the composition of the Board and Remuneration Committee will be as: Eddy Lee Yip Hang, Executive Chairman and Chief Executive Officer; Albert Ho Shing Tung, Non-Executive Director; Low Weng Keong, Non-Executive Lead Independent Director; Claudia Teo Kwee Yee, Non-Executive Independent Director. Remuneration Committee: Claudia Teo Kwee Yee, Chairman; Low Weng Keong, Member; and Albert Ho Shing Tung, Member.